As the new coronavirus continues its spread, pharma companies are finding themselves facing a spate of challenges. And although they’ll need to find ways to counter those setbacks, they also can help address issues facing other health care industry stakeholders.
“This is an unprecedented time and one that is full of challenges for companies of all sizes and in all sectors,” observes Mike DeLone, principal at Deloitte Consulting and U.S. life sciences sector leader. “We believe there are five fundamental qualities of resilient leadership that should serve as guiding principles now more than ever: Be genuinely, sincerely empathetic while maintaining a hard, rational line to protect financial performance; put the mission first; aim for speed over elegance; own the narrative; and embrace the long view. While it will take time and effort, this crisis can become an opportunity to move forward and create even more value and positive societal impact.”